William John Sibold, President and CEO: Madrigal Pharmaceuticals MDGL Sell · Filed 25/08/21

Trade details

Type: Insider sale
Amount: $2,594,194.55
Shares · price: 6,485 sh · $400.03 a share
Held after: 110,884 sh
Stock: Madrigal Pharmaceuticals MDGL
Person: William John SiboldPresident and CEO
Trade date: 25/08/21
Filed: 25/08/21
Days to filing: 0 days

Sold 5.5% of holdings

Share of holding sold: 5.5%

Madrigal Pharmaceuticals trades, last 26 weeks

What else happened in Madrigal Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/07/22~25/09/20

William John Sibold's recent trades

William John SiboldPresident and CEO
Planned sale10b5-1 planMadrigal Pharmaceuticals
Planned sale10b5-1 plan
Madrigal Pharmaceuticals
MDGL
$2.8M
5,221 sh
$2.8M
Filed 09/11
Traded 09/11
William John SiboldPresident and CEO
Planned saleMadrigal Pharmaceuticals
Planned sale
Madrigal Pharmaceuticals
MDGL
$3.4M
6,362 sh
$3.4M
Filed 09/09
Traded 09/09
William John SiboldPresident and CEO
Planned saleMadrigal Pharmaceuticals
Planned sale
Madrigal Pharmaceuticals
MDGL
$1.4M
2,500 sh
$1.4M
Filed 07/20
Traded 07/20
William John SiboldPresident and CEO
SellMadrigal Pharmaceuticals
Sell
Madrigal Pharmaceuticals
MDGL
$718.3K
1,663 sh
$718.3K
Filed 03/06
Traded 03/06
William John SiboldPresident and CEO
Planned saleMadrigal Pharmaceuticals
Planned sale
Madrigal Pharmaceuticals
MDGL
$730.6K
1,663 sh
$730.6K
Filed 03/06
Traded 03/06

William John Sibold, CEO — sold $2.6M of Madrigal Pharmaceuticals MDGL · 5.5% of holdings · 10b5-1 plan | Whalegun